EDP Sciences logo
rechercher
Menu
Accueil Tous les numéros Numéro 25 (juillet 2022) Cah. Myol., 25 (2022) 23-29 References
Open Access
Issue
Cah. Myol.
Number 25, juillet 2022
Page(s) 23 - 29
Section Mise au point / Focus
DOI https://doi.org/10.1051/myolog/202225006
Published online 11 août 2022
  1. Satoyoshi E, Kinoshita M. Oculopharyngodistal myopathy. Arch Neurol 1977 Feb ; 34 (2) : 89–92. [CrossRef] [PubMed] [Google Scholar]
  2. Deng J, Yu J, Li P, et al. Expansion of GGC Repeat in GIPC1 Is Associated with Oculopharyngodistal Myopathy. Am J Hum Genet 2020 Jun 4 ; 106 (6) : 793–804. [CrossRef] [PubMed] [Google Scholar]
  3. Durmus H, Laval SH, Deymeer F, et al. Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients. Neurology 2011 Jan 18 ; 76 (3) : 227–35. [CrossRef] [PubMed] [Google Scholar]
  4. Zhao J, Liu J, Xiao J, et al. Clinical and muscle imaging findings in 14 mainland chinese patients with oculopharyngodistal myopathy. PLoS One 2015 Jun 3 ; 10 (6) : e0128629. [CrossRef] [PubMed] [Google Scholar]
  5. Ogasawara M, Iida A, Kumutpongpanich T, et al. CGG expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy with neurological manifestations. Acta Neuropathol Commun 2020 Nov 25 ; 8 (1) : 204. [CrossRef] [PubMed] [Google Scholar]
  6. Ishiura H, Shibata S, Yoshimura J, et al. Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet 2019 Aug ; 51 (8) : 1222–232. [CrossRef] [PubMed] [Google Scholar]
  7. Xi J, Wang X, Yue D, et al. 5’ UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathy. Brain 2021 Mar 3 ; 144 (2) : 601–14. [CrossRef] [PubMed] [Google Scholar]
  8. Yu J, Deng J, Guo X, et al. The GGC repeat expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy type 3. Brain 2021 Jul 28 ; 144 (6) : 1819–32. [CrossRef] [PubMed] [Google Scholar]
  9. Yu J, Shan J, Yu M, et al. The CGG repeat expansion in RILPL1 is associated with oculopharyngodistal myopathy type 4. Am J Hum Genet 2022 Mar 3 ; 109 (3) : 533–41. [CrossRef] [PubMed] [Google Scholar]
  10. Lee JE, Cooper TA. Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 2009 Dec ; 37 : 1281–6. [CrossRef] [PubMed] [Google Scholar]
  11. Liquori CL, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001 Aug 3 ; 293 (5531) : 864–7. [CrossRef] [PubMed] [Google Scholar]
  12. Miller JW, Urbinati CR, Teng-Umnuay P, et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000 Sep 1 ; 19 (17) : 4439–48. [CrossRef] [PubMed] [Google Scholar]
  13. Ho TH, Charlet-B N, Poulos MG, et al. Muscleblind proteins regulate alternative splicing. EMBO J 2004 Aug 4 ; 23 (15) : 3103–12. [CrossRef] [PubMed] [Google Scholar]
  14. Dansithong W, Paul S, Comai L, et al. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J Biol Chem 2005 ; 280 : 5773–80. [CrossRef] [PubMed] [Google Scholar]
  15. Tomé FM, Fardeau M. Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropathol 1980 ; 49(1) : 85–7. [CrossRef] [PubMed] [Google Scholar]
  16. Brais B, Bouchard JP, Xie YG, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998 Feb ; 18 (2) : 164–7. [CrossRef] [PubMed] [Google Scholar]
  17. Calado A, Tomé FM, Brais B, et al. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum Mol Genet 2000 Sep 22 ; 9 (15) : 2321–8. [CrossRef] [PubMed] [Google Scholar]
  18. Trollet C, Anvar SY, Venema A, et al. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres. Hum Mol Genet 2010 Jun 1 ; 19 (11) : 2191–207. [CrossRef] [PubMed] [Google Scholar]
  19. Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 2003 Apr ; 72 (4) : 869–78. [CrossRef] [PubMed] [Google Scholar]
  20. Greco CM, Hagerman RJ, Tassone F, et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 2002 Aug ; 125 : 1760–71. [CrossRef] [PubMed] [Google Scholar]
  21. Greco CM, Berman RF, Martin RM, et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 2006 Jan ; 129 : 243–55. [CrossRef] [PubMed] [Google Scholar]
  22. Hunsaker MR, Greco CM, Spath MA, et al. Widespread noncentral nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol 2011 Oct ; 122 (4) : 467–79. [CrossRef] [PubMed] [Google Scholar]
  23. Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001 Jul 10 ; 57 (1) : 127–30. [CrossRef] [PubMed] [Google Scholar]
  24. Oberlé I, Rousseau F, Heitz D, et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991 May 24 ; 252 (5009) : 1097–102. [CrossRef] [PubMed] [Google Scholar]
  25. Coffee B, Zhang F, Warren ST, et al. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet 1999 May ; 22 (1) : 98–101. [CrossRef] [PubMed] [Google Scholar]
  26. Tassone F, Hagerman RJ, Loesch DZ, et al. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet 2000 Sep 18 ; 94 (3) : 232–6. [CrossRef] [PubMed] [Google Scholar]
  27. Todd PK, Oh SY, Krans A, et al. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 2013 May 8 ; 78 (3) : 440–55. [CrossRef] [PubMed] [Google Scholar]
  28. Sellier C, Buijsen RAM, He F, et al. Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome. Neuron 2017 Jan 18 ; 93 (2) : 331–47. [CrossRef] [PubMed] [Google Scholar]
  29. Kozak M. Context effects and inefficient initiation at non-AUG codons in eucaryotic cell-free translation systems. Mol Cell Biol 1989 Nov ; 9 (11) : 5073–80. [PubMed] [Google Scholar]
  30. Sone J, Mitsuhashi S, Fujita A, et al. Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet 2019 Aug ; 51 (8) : 1215–21. [CrossRef] [PubMed] [Google Scholar]
  31. Gelpi E, Botta-Orfila T, Bodi L, et al. Neuronal intranuclear (hyaline) inclusion disease and fragile X-associated tremor/ataxia syndrome: a morphological and molecular dilemma. Brain 2017 Aug 1 ; 140 (8) : e51. [CrossRef] [PubMed] [Google Scholar]
  32. Kimber TE, Blumbergs PC, Rice JP, et al. Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions. J Neurol Sci 1998 Sep 18 ; 160 (1) : 33–40. [CrossRef] [PubMed] [Google Scholar]
  33. Deng J, Gu M, Miao Y, et al. Long-read sequencing identified repeat expansions in the 5’UTR of the NOTCH2NLC gene from Chinese patients with neuronal intranuclear inclusion disease. J Med Genet 2019 Nov ; 56 (11) : 758–64. [CrossRef] [PubMed] [Google Scholar]
  34. Tian Y, Wang JL, Huang W, et al. Expansion of HumanSpecific GGC Repeat in Neuronal Intranuclear Inclusion DiseaseRelated Disorders. Am J Hum Genet 2019 Jul 3 ; 105 (1) : 166–76. [CrossRef] [PubMed] [Google Scholar]
  35. Boivin M, Deng J, Pfister V, et al. Translation of GGC repeat expansions into a toxic polyglycine protein in NIID defines a novel class of human genetic disorders: The polyG diseases. Neuron 2021 Jun 2 ; 109 (11) : 1825–35. [CrossRef] [PubMed] [Google Scholar]
  36. Zhong S, Lian Y, Luo W, et al. Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases. Acta Neuropathol 2021 Oct 25. [PubMed] [Google Scholar]
  37. Boivin M, Charlet-Berguerand N. Trinucleotide CGG Repeat Diseases: An Expanding Field of Polyglycine Proteins ? Front Genet 2022 Feb 28 ; 13 : 843014. [CrossRef] [PubMed] [Google Scholar]
  38. Fukuda H, Yamaguchi D, Nyquist K, et al. Father-to-offspring transmission of extremely long NOTCH2NLC repeat expansions with contractions: genetic and epigenetic profiling with long-read sequencing. Clin Epigenetics 2021 Nov 13 ; 13 (1) : 204. [CrossRef] [PubMed] [Google Scholar]
  39. Kumutpongpanich T, Ogasawara M, Ozaki A, et al. Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes. JAMA Neurol 2021 Jul 1 ; 78 (7) : 853–63. [CrossRef] [PubMed] [Google Scholar]
  40. Xu K, Li Y, Allen EG, et al. Therapeutic Development for CGG Repeat Expansion-Associated Neurodegeneration. Front Cell Neurosci 2021 May ; 12 (15) : 655568. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.